Bisamide sarcomere activating compounds and uses therof
申请人:AMGEN INC.
公开号:US10723720B2
公开(公告)日:2020-07-28
The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising a compound of the invention, a method for manufacturing compounds of the invention and therapeutic uses thereof.
Bisamide sarcomere activating compounds and uses thereof
申请人:AMGEN INC.
公开号:US10899746B2
公开(公告)日:2021-01-26
The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising a compound of the invention, a method for manufacturing compounds of the invention and therapeutic uses thereof.
[EN] BISAMIDE SARCOMERE ACTIVATING COMPOUNDS AND USES THEREOF<br/>[FR] COMPOSÉS ACTIVATEURS DE BISAMIDE SARCOMÈRE ET LEURS UTILISATIONS
申请人:AMGEN INC
公开号:WO2019055590A1
公开(公告)日:2019-03-21
The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising a compound of the invention, a method for manufacturing compounds of the invention and therapeutic uses thereof.